New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells

The androgen deprivation therapy (ADT) to systematically suppress/reduce androgens binding to the androgen receptor (AR) has been the standard therapy for prostate cancer (PCa); yet, most of ADT eventually fails leading to the recurrence of castration resistant PCa. Here, we found that the PCa patie...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lee, Soo Ok, Ma, Zhifang, Yeh, Chiuan-Ren, Luo, Jie, Lin, Tzu-Hua, Lai, Kuo-Pao, Yamashita, Shinichi, Liang, Liang, Tian, Jing, Li, Lei, Jiang, Qi, Huang, Chiung-Kuei, Niu, Yuanjie, Yeh, Shuyuan, Chang, Chawnshang
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2013
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3570051/
https://ncbi.nlm.nih.gov/pubmed/22831834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jmcb/mjs042
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars